Original language | English |
---|---|
Pages (from-to) | 7-7 |
Number of pages | 1 |
Journal | European Journal of Cancer |
Volume | 50 |
DOIs | |
Publication status | Published - Nov 2014 |
Event | 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Barcelona, Spain Duration: 18 Nov 2014 → 21 Nov 2014 |
Afuresertib (GSK2110183), an oral AKT kinase inhibitor, in combination with carboplatin and paclitaxel in recurrent ovarian cancer
S. Blagden, A. Hamilton, Linda Mileshkin, M. Hall, T. Meniawy, S. Wong, S. Anandra, M. Buck, D. McAleer, B. A. Reedy, R. B. Noble, D. A. Smith, S. R. Morris, H. Gabra
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
5
Citations
(Web of Science)